Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China

Shao-Lee Lin, new Cue Biopharma CEO May 1, 2026 11:27 AM EDT PeopleDealsChina Ace­lyrin founder Shao-Lee Lin emerges at Cue, as it be­comes lat­est to li­cense from Chi­na Lei Lei Wu News Reporter Cue Bio­phar­ma an­nounced a re­boot Thurs­day af­ter­noon, bring­ing in no­table biotech ex­ec­u­tive Shao-Lee Lin as well as a new al­ler­gy as­set de­vel­oped in Tai­wan and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER